These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 1132298)

  • 41. [Intermediate evaluation of a prospective study of the therapy of malignant non-Hodgkin lymphomas].
    Jandl H; Franke A; Kammerer R; Spormann H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(5):678-84. PubMed ID: 6172333
    [No Abstract]   [Full Text] [Related]  

  • 42. Patient protection in cancer chemotherapy.
    Schwartz SA; Perry S
    JAMA; 1966 Aug; 197(8):623-7. PubMed ID: 5953092
    [No Abstract]   [Full Text] [Related]  

  • 43. [Experiences in the chemotherapy of malignant histiocytosis].
    Herold M; Wutke K; Höche D; Rüdiger KD
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(5):694-8. PubMed ID: 6172336
    [No Abstract]   [Full Text] [Related]  

  • 44. [Therapy of metastasizing solid tumors with cyclophosphamide, methotrexate, vincristine and 5-fluorouracil].
    Fritsch H; Castor H; Drings P; Moskwa G
    Verh Dtsch Ges Inn Med; 1973; 79():1373-6. PubMed ID: 4790188
    [No Abstract]   [Full Text] [Related]  

  • 45. Dissociation of lymphotoxin production and lymphocyte blast cell transformation in acute lymphoblastic leukemia after cessation of long-term immunosuppressive therapy.
    Eife R; Trowitzsch L; Lampert F
    Klin Padiatr; 1974 Nov; 186(6):483-8. PubMed ID: 4548474
    [No Abstract]   [Full Text] [Related]  

  • 46. The role played by radiotherapy in the UKALL III series of trials for the treatment of acute lymphoblastic leukaemia in childhood.
    Hathaway FK
    Radiography; 1974 Nov; 40(479):255-8. PubMed ID: 4618915
    [No Abstract]   [Full Text] [Related]  

  • 47. [The immunosuppressive agents. 3. The immunosuppressive agents in hematology].
    Meshaka G; Jacquillat C; Sultan Y
    Presse Med (1893); 1967 Jul; 75(32):1653-5. PubMed ID: 6067478
    [No Abstract]   [Full Text] [Related]  

  • 48. An evaluation of five drug combination chemotherapy in the management of recurrent carcinoma of the breast.
    Lee JM; Abeloff MD; Lenhard RE; Baker RR
    Surg Gynecol Obstet; 1974 Jan; 138(1):77-80. PubMed ID: 4809006
    [No Abstract]   [Full Text] [Related]  

  • 49. [Cytostatic combination therapy in metastatic breast cancer].
    Mouridsen HT
    Ugeskr Laeger; 1973 Jun; 135(25):1336-40. PubMed ID: 4757127
    [No Abstract]   [Full Text] [Related]  

  • 50. [Control studies on the cytostatic combination therapy in metastasizing breast carcinoma].
    Brunner KW; Martz G; Senn HJ; Obrecht P; Alberto P; Melchert F
    Internist (Berl); 1973 Dec; 14(12):643-52. PubMed ID: 4593011
    [No Abstract]   [Full Text] [Related]  

  • 51. Immunosuppressive therapy.
    Winkelstein A; Segel D; Stolzer BL; Fogel M; Shadduck RK; Lewis M
    Am J Med Sci; 1973 Feb; 265(2):92-108. PubMed ID: 4736193
    [No Abstract]   [Full Text] [Related]  

  • 52. Treatment of acute leukemia in adults. Results with a combination of potent cytotoxic drugs.
    Stavem P; Gjemdal T
    Acta Med Scand; 1974; 196(1-2):121-5. PubMed ID: 4529548
    [No Abstract]   [Full Text] [Related]  

  • 53. Variations in responsiveness and survival of clinical subsets of patients with metastatic breast cancer to two chemotherapy combinations.
    Smalley RV; Bartolucci AA
    Eur J Cancer (1965); 1980; Suppl 1():141-6. PubMed ID: 7318861
    [No Abstract]   [Full Text] [Related]  

  • 54. Effects of 2,2'(methylenediimino)bis-1,3,4-thiadiazole (NSC-143019) on tumor growth and immune responses in mice.
    Matsumoto T; Ootsu K; Okada Y
    Cancer Chemother Rep; 1974; 58(3):331-44. PubMed ID: 4152218
    [No Abstract]   [Full Text] [Related]  

  • 55. [Immunosuppressive agents in complex treatment of disseminated sclerosis].
    Agte BS; Zemlianaia NF; Kalmykova TN; Dukhovnaia MA
    Sov Med; 1976 Nov; (11):53-7. PubMed ID: 1006393
    [No Abstract]   [Full Text] [Related]  

  • 56. [Present status of the melanoma problem].
    Braun W; Lübbe D; Wohlrab W; Wozniak KD; Zaumseil RP
    Dermatol Monatsschr; 1979 Oct; 165(10):732-40. PubMed ID: 393546
    [No Abstract]   [Full Text] [Related]  

  • 57. [Value of thymodependant rosette tests in the surveillance of malignant melanoma. Preliminary study apropos of 25 cases].
    Claudy A; Fouad-Wassef N; Pelletier N
    Ann Dermatol Syphiligr (Paris); 1975; 102(1):69-70. PubMed ID: 1084114
    [No Abstract]   [Full Text] [Related]  

  • 58. Mechanism of eosinophilia. 3. Suppression of eosinophilia by agents known to modify immune responses.
    Boyer MH; Basten A; Beeson PB
    Blood; 1970 Oct; 36(4):458-69. PubMed ID: 5455269
    [No Abstract]   [Full Text] [Related]  

  • 59. [Mechanism of the anti-inflammatory action of immunodepressants].
    Zaks AS; Rabotnikov IuM; Ovodenko LA; Zil'bermints LG
    Farmakol Toksikol; 1977; 40(5):578-82. PubMed ID: 923780
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Immunologic and chemotherapeutic effects on human melanoma heterotransplant.
    Sommers SC; Reeves G; Reeves E
    Proc Soc Exp Biol Med; 1966 Dec; 123(3):740-2. PubMed ID: 5959775
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.